To determine the effect of daily administration of 40 mgms simvastatin taken for at least 12
months (range 12-36 months) on the frequency of exacerbations of chronic obstructive lung
disease (COPD) in patients with moderate to severe COPD who are prone to exacerbations and do
not have other indications for statin treatment.
Phase:
Phase 3
Details
Lead Sponsor:
University of Minnesota University of Minnesota - Clinical and Translational Science Institute
Collaborators:
Canadian Institutes of Health Research (CIHR) National Heart, Lung, and Blood Institute (NHLBI) Ottawa Hospital Research Institute